Fudan Zhangjiang

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (abbreviated as: Fudan Zhangjiang, stock code: A-share 688505 / H-share 1349) was founded in 1996 in Zhangjiang Hi-Tech Park, Pudong, Shanghai (Zhangjiang Medicine Valley). It is one of the few bio-pharmaceutical companies in China listed on both A-shares and H-shares. With the mission of "Every bit of our exploration brings more health to humanity," we are committed to exploring unmet clinical needs and providing patients with more effective treatment options and drugs, aspiring to become an innovator and leader in the global bio-pharmaceutical field. Our strengths and advantages: Full industry chain layout: We integrate innovative R&D, manufacturing, and marketing, possessing complete capabilities from laboratory to market. Leading technology platforms: We have established and deeply cultivated four core R&D platforms: genetic engineering technology, photodynamic technology (world-class level), nanotechnology, and oral solid dosage form technology, building solid technical barriers. Focused therapeutic areas and blockbuster products: Our product pipeline focuses on major therapeutic areas such as dermatology and venereology, malignant tumors, and autoimmune diseases. Our flagship products, such as Aila®, have won multiple honors including the National High-Tech Industrialization Project and Shanghai Independent Innovation Products. Strong scientific backing: The company has undertaken national major science and technology projects such as the "National High-Tech R&D Program (863 Program)" and "Major New Drug Creation," with R&D strength recognized nationally. Join us: If you are eager to create value in the wave of bio-pharmaceuticals, and if you wish that every bit of your exploration can light up the future of human health, Fudan Zhangjiang will provide you with the ideal stage. We are waiting for you, looking forward to writing together the next legend of health and innovation!